UMIN ID: UMIN000049417
Registered date:02/11/2022
VOice-guided AI Cancer Evaluation (VOICE) Study
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Lung Cancer |
| Date of first enrollment | 2021/08/06 |
| Target sample size | 300 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Developing a platform for voice-activated cancer diagnosis |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients deemed inappropriate by the principal investigator or subinvestigator |
Related Information
| Primary Sponsor | National Cancer Center Hospital, Japan |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Axe co. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Akiko Tateishi |
| Address | 5-1-1. Tsukiji Chuoku, Tokyo, Japan Japan 104-0045 |
| Telephone | 03-3542-2511 |
| atateish@ncc.go.jp | |
| Affiliation | National Cancer Center Hospital, Japan Thoracic Oncology Department |
| scientific contact | |
| Name | Takafumi Koyama |
| Address | 5-1-1. Tsukiji Chuoku, Tokyo, Japan Japan |
| Telephone | 03-3542-2511 |
| takoyama@ncc.go.jp | |
| Affiliation | National Cancer Center Hospital, Japan Developmental Therapeutics Department |